Root Financial Partners
ANIK icon

Root Financial Partners’s Anika Therapeutics ANIK Stock Holding History

Root Financial Partners’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.15K Buy
+160
New +$3.06K ﹤0.01% 2419
2026
Q2 		– Sell
-67
Closed -$972 – 553
2026
Q1 		$972 Buy
+67
New +$778 ﹤0.01% 2626

Other funds holding ANIK

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $668M AUM 8.93% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Root Financial Partners's ANIK Position: Q3 2026 in Review

Root Financial Partners opened a new position in Anika Therapeutics (ANIK) in Q3 2026: 160 shares worth $3.15K. The stake represents ﹤0.01% of the portfolio and ranks #2419 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in ANIK as recently as Q1 2026.

Root Financial Partners first reported a position in ANIK in Q1 2026 and has held it in 2 quarters since. 97 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

  • Root Financial Partners held 160 shares of Anika Therapeutics worth $3.15K as of Q3 2026.
  • Anika Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Anika Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2419 holding.
  • Root Financial Partners first reported a position in Anika Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 97 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.